Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

Gastrointestinal Drugs Global Market Report 2022

Starting Price : $5000.00 | Pages : 300 | Published : January 2022 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

The gastrointestinal drugs market consists of sales of gastrointestinal drugs by entities (organizations, sole traders and partnerships) that produce gastrointestinal drugs to treat gastrointestinal diseases such as ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors, Sucralfate, and Misoprostol), antiemetics, adsorbents, anticholinergics, opiates, intestinal flora modifiers, emollient/surfactants, hyperosmotic, saline, and simulant/irritant.

The main types of gastrointestinal drugs are antacids, antiulcerants, vitamin and minerals, antiobesity, antiemetics and antinauseants and antidiarrhoeals. Antacids are medications that counteract (neutralise) stomach acid to relieve indigestion and heartburn. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores and others.

The global gastrointestinal drugs market size is expected to grow from $71.85 billion in 2021 to $75.63 billion in 2022 at a compound annual growth rate (CAGR) of 5.3%. The change in the gastrointestinal drugs market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The gastrointestinal drugs market is expected to reach $105.51 billion in 2026 at a CAGR of 8.7%.

The aging population profile of most countries will contribute to the growth of the gastrointestinal drugs market. The increase in patient pool due to rising geriatric population globally, will contribute significantly to the growth of the market during the forecast period. According to the WHO, by 2030, one in every six people on the planet will be 60 or older. The proportion of the population aged 60 and up will rise from 1 billion in 2020 to 2.2 billion by 2050. This rise in the geriatric population increased the demand for medical care and drove the healthcare expenditure. This will led to increased demand for pharmaceuticals products, significantly impacting market growth during this period.

During the forecast period, the growth of the gastrointestinal drugs market will be restrained by patent expiration of branded gastrointestinal drugs. In general, pharmaceutical companies invest a large sum of money in the drug development process and patents. During the patency period, the company holding the patent holds exclusivity for the manufacturing and distribution of drugs. Post expiration of patency, generic versions of the drugs are manufactured by other companies with prices much lower than the original branded drugs. Overall, this will negatively impact the growth of the market in terms of value.

Major companies in the gastrointestinal drug industry are investing in making oral capsules of macromolecular drugs for gastrointestinal diseases for making the drug more effective. Macromolecular drugs, such as peptides, proteins, and antibodies, form a new class of drugs which can treat diseases of the gastrointestinal tract, such as inflammatory bowel disease. These macromolecular drugs are usually injected and only a fraction of the administered dose reaches the disease sites in the gastrointestinal tract. Thus, major companies such as Eli Lilly have been increasingly investing in making oral capsules for macromolecular drugs. The company invested $5 million to enter into a collaboration with Entrega to study the oral delivery of complex molecules, such as peptides to combat gastrointestinal diseases.

Major companies in the gastrointestinal drugs market include Takeda Pharmaceuticals, Bayer AG, Abbott Laboratories, Otsuka Holdings Co ltd, Johnson & Johnson, Reckitt Benckiser Group plc, Bausch Health Companies Inc., Sanofi S.A, Procter & Gamble and Daiichi Sankyo Company.

North America was the largest region in the gastrointestinal drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the gastrointestinal drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gastrointestinal drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam.

The global gastrointestinal drugs market is segmented -

1) By Type: Antacids, Antiulcerants, Vitamin and Minerals, Antiobesity, Antiemetics and Antinauseants, Antidiarrhoeals

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

    Table Of Contents

    1. Executive Summary

    2. Report Structure

    3. Gastrointestinal Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Gastrointestinal Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Gastrointestinal Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Gastrointestinal Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Gastrointestinal Drugs Market Trends And Strategies

    8. Impact Of COVID-19 On Gastrointestinal Drugs

    9. Gastrointestinal Drugs Market Size And Growth

    9.1. Market Size

    9.2. Historic Market Growth, Value ($ Billion)

    9.2.1. Drivers Of The Market

    9.2.2. Restraints On The Market

    9.3. Forecast Market Growth, Value ($ Billion)

    9.3.1. Drivers Of The Market

    9.3.2. Restraints On The Market

    10. Gastrointestinal Drugs Market Regional Analysis

    10.1. Global Gastrointestinal Drugs Market, 2021, By Region, Value ($ Billion)

    10.2. Global Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

    10.3. Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Region

    11. Gastrointestinal Drugs Market Segmentation

    11.1. Global Gastrointestinal Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Antacids

    Antiulcerants

    Vitamin And Minerals

    Antiobesity

    Antiemetics And Antinauseants

    Antidiarrhoeals

    11.2. Global Gastrointestinal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    11.3. Global Gastrointestinal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Oral

    Parenteral

    Others

    11.4. Global Gastrointestinal Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Branded Drugs

    Generic Drugs

    11.5. Global Gastrointestinal Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    12. Gastrointestinal Drugs Market Metrics

    12.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, 2016-2026, Global

    12.2. Per Capita Average Gastrointestinal Drugs Market Expenditure, 2016-2026, Global

    13. Asia-Pacific Gastrointestinal Drugs Market

    13.1. Asia-Pacific Gastrointestinal Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    13.2. Asia-Pacific, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)

    13.3. Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    13.4. Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    13.5. Asia-Pacific, Gastrointestinal Drugs Market Metrics

    13.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Asia-Pacific Countries

    13.6. Asia-Pacific Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7. Asia-Pacific Gastrointestinal Drugs Market: Country Analysis

    13.7.1. China Gastrointestinal Drugs Market

    13.7.1.1. China Gastrointestinal Drugs Market Overview

    13.7.1.2. China Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.1.3. China Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.2. Australia Gastrointestinal Drugs Market

    13.7.2.1. Australia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.2.2. Australia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.3. Hong Kong Gastrointestinal Drugs Market

    13.7.3.1. Hong Kong Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.4. India Gastrointestinal Drugs Market

    13.7.4.1. India Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.4.2. India Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.5. Indonesia Gastrointestinal Drugs Market

    13.7.5.1. Indonesia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.5.2. Indonesia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.6. Japan Gastrointestinal Drugs Market

    13.7.6.1. Japan Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.6.2. Japan Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.7. Malaysia Gastrointestinal Drugs Market

    13.7.7.1. Malaysia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.8. New Zealand Gastrointestinal Drugs Market

    13.7.8.1. New Zealand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.9. Philippines Gastrointestinal Drugs Market

    13.7.9.1. Philippines Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.10. Singapore Gastrointestinal Drugs Market

    13.7.10.1. Singapore Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.11. South Korea Gastrointestinal Drugs Market

    13.7.11.1. South Korea Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.11.2. South Korea Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.12. Thailand Gastrointestinal Drugs Market

    13.7.12.1. Thailand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.13. Vietnam Gastrointestinal Drugs Market

    13.7.13.1. Vietnam Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14. Western Europe Gastrointestinal Drugs Market

    14.1. Western Europe Gastrointestinal Drugs Market Overview

    14.2. Western Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)

    14.3. Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    14.4. Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    14.5. Western Europe, Gastrointestinal Drugs Market Metrics

    14.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Western Europe Countries

    14.6. Western Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7. Western Europe Gastrointestinal Drugs Market: Country Analysis

    14.7.1. Austria Gastrointestinal Drugs Market

    14.7.1.1. Austria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.2. Belgium Gastrointestinal Drugs Market

    14.7.2.1. Belgium Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.3. Denmark Gastrointestinal Drugs Market

    14.7.3.1. Denmark Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.4. Finland Gastrointestinal Drugs Market

    14.7.4.1. Finland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.5. France Gastrointestinal Drugs Market

    14.7.5.1. France Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.5.2. France Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.6. Germany Gastrointestinal Drugs Market

    14.7.6.1. Germany Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.6.2. Germany Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.7. Ireland Gastrointestinal Drugs Market

    14.7.7.1. Ireland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.8. Italy Gastrointestinal Drugs Market

    14.7.8.1. Italy Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.9. Netherlands Gastrointestinal Drugs Market

    14.7.9.1. Netherlands Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.10. Norway Gastrointestinal Drugs Market

    14.7.10.1. Norway Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.11. Portugal Gastrointestinal Drugs Market

    14.7.11.1. Portugal Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.12. Spain Gastrointestinal Drugs Market

    14.7.12.1. Spain Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.13. Sweden Gastrointestinal Drugs Market

    14.7.13.1. Sweden Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.14. Switzerland Gastrointestinal Drugs Market

    14.7.14.1. Switzerland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.15. UK Gastrointestinal Drugs Market

    14.7.15.1. UK Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.15.2. UK Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15. Eastern Europe Gastrointestinal Drugs Market

    15.1. Eastern Europe Gastrointestinal Drugs Market Overview

    15.2. Eastern Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)

    15.3. Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    15.4. Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    15.5. Eastern Europe, Gastrointestinal Drugs Market Metrics

    15.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Eastern Europe Countries

    15.6. Eastern Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7. Eastern Europe Gastrointestinal Drugs Market: Country Analysis

    15.7.1. Czech Republic Gastrointestinal Drugs Market,  

    15.7.1.1. Czech Republic Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.2. Poland Gastrointestinal Drugs Market

    15.7.2.1. Poland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.3. Romania Gastrointestinal Drugs Market

    15.7.3.1. Romania Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.4. Russia Gastrointestinal Drugs Market

    15.7.4.1. Russia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.4.2. Russia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16. North America Gastrointestinal Drugs Market

    16.1. North America Gastrointestinal Drugs Market Overview

    16.2. North America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)

    16.3. North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    16.4. North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    16.5. North America, Gastrointestinal Drugs Market Metrics

    16.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, North America Countries

    16.6. North America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7. North America Gastrointestinal Drugs Market: Country Analysis

    16.7.1. Canada Gastrointestinal Drugs Market

    16.7.1.1. Canada Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.2. Mexico Gastrointestinal Drugs Market

    16.7.2.1. Mexico Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.3. USA Gastrointestinal Drugs Market

    16.7.3.1. USA Gastrointestinal Drugs Market Overview

    16.7.3.2. USA Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.3.3. USA Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17. South America Gastrointestinal Drugs Market

    17.1. South America Gastrointestinal Drugs Market Overview

    17.2. South America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)

    17.3. South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    17.4. South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    17.5. South America, Gastrointestinal Drugs Market Metrics

    17.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, South America Countries

    17.6. South America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7. South America Gastrointestinal Drugs Market: Country Analysis

    17.7.1. Argentina Gastrointestinal Drugs Market

    17.7.1.1. Argentina Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.2. Brazil Gastrointestinal Drugs Market

    17.7.1.1. Brazil Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.2.2. Brazil Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.3. Chile Gastrointestinal Drugs Market

    17.7.3.1. Chile Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.4. Colombia Gastrointestinal Drugs Market

    17.7.4.1. Colombia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.5. Peru Gastrointestinal Drugs Market

    17.7.5.1. Peru Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.6. Venezuela Gastrointestinal Drugs Market

    17.7.6.1. Venezuela Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18. Middle East Gastrointestinal Drugs Market

    18.1. Middle East Gastrointestinal Drugs Market Overview

    18.2. Middle East, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)

    18.3. Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    18.4. Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    18.5. Middle East, Gastrointestinal Drugs Market Metrics

    18.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Middle East Countries

    18.6. Middle East Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7. Middle East Gastrointestinal Drugs Market: Country Analysis

    18.7.1. Saudi Arabia Gastrointestinal Drugs Market

    18.7.1.1. Saudi Arabia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.2. Israel Gastrointestinal Drugs Market

    18.7.2.1. Israel Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.3. Turkey Gastrointestinal Drugs Market

    18.7.3.1. Turkey Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.4. UAE Gastrointestinal Drugs Market

    18.7.4.1. UAE Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19. Africa Gastrointestinal Drugs Market

    19.1. Africa Gastrointestinal Drugs Market Overview

    19.2. Africa, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)

    19.3. Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    19.4. Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    19.5. Africa, Gastrointestinal Drugs Market Metrics

    19.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Africa Countries

    19.6. Africa Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7. Africa Gastrointestinal Drugs Market: Country Analysis

    19.7.1. Egypt Gastrointestinal Drugs Market

    19.7.1.1. Egypt Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7.2. Nigeria Gastrointestinal Drugs Market

    19.7.2.1. Nigeria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7.3. South Africa Gastrointestinal Drugs Market

    19.7.3.1. South Africa Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    20. Gastrointestinal Drugs Market Competitive Landscape

    20.1. Competitive Market Overview

    20.2. Market Shares

    20.3. Company Profiles

    20.3.1. Takeda Pharmaceuticals

    20.3.1.1. Company Overview

    20.3.1.2. Products And Services

    20.3.1.3. Strategy

    20.3.1.4. Financial Performance

    20.3.2. Bayer AG

    20.3.2.1. Company Overview

    20.3.2.2. Products And Services

    20.3.2.3. Strategy

    20.3.2.4. Financial Performance

    20.3.3. Abbott Laboratories

    20.3.3.1. Company Overview

    20.3.3.2. Products And Services

    20.3.3.3. Strategy

    20.3.3.4. Financial Performance

    20.3.4. Otsuka Holdings Co ltd

    20.3.4.1. Company Overview

    20.3.4.2. Products And Services

    20.3.4.3. Strategy

    20.3.4.4. Financial Performance

    20.3.5. Johnson & Johnson

    20.3.5.1. Company Overview

    20.3.5.2. Products And Services

    20.3.5.3. Strategy

    20.3.5.4. Financial Performance

    21. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market

    22. Market Background: Pharmaceutical Drugs Market

    22.1. Pharmaceutical Drugs Market Characteristics

    22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global

    22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

    22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

    22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

    23. Recommendations

    23.1. Global Gastrointestinal Drugs Market In 2026- Growth Countries

    23.2. Global Gastrointestinal Drugs Market In 2026- Growth Segments

    23.3. Global Gastrointestinal Drugs Market In 2026- Growth Strategies

    24. Appendix

    24.1. NAICS Definitions Of Industry Covered In This Report

    24.2. Abbreviations

    24.3. Currencies

    24.4. Research Inquiries

    24.5. The Business Research Company

    25. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Gastrointestinal Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 4: Global Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 5: Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Gastrointestinal Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Gastrointestinal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Global Gastrointestinal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Global Gastrointestinal Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: Global Gastrointestinal Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Gastrointestinal Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Table 12: Per Capita Average Gastrointestinal Drugs Market Expenditure, 2016-2026, Global
  • Table 13: Asia-Pacific, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Table 17: Asia-Pacific Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 18: China Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 19: China Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 20: Australia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 21: Australia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 22: Hong Kong Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 23: India Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 24: India Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 25: Indonesia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 26: Indonesia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 27: Japan Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 28: Japan Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 29: Malaysia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 30: New Zealand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 31: Philippines Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 32: Singapore Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 33: South Korea Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 34: Thailand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 35: Vietnam Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 36: Western Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 37: Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 38: Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 39: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Western Europe Countries
  • Table 40: Western Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 41: Austria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 42: Belgium Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 43: Denmark Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 44: Finland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 45: France Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 46: France Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 47: Germany Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 48: Germany Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 49: Ireland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 50: Italy Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 51: Netherlands Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 52: Norway Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 53: Portugal Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 54: Spain Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 55: Sweden Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 56: Switzerland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 57: UK Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 58: UK Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 59: Eastern Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 60: Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 61: Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 62: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Table 63: Eastern Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 64: Czech Republic Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 65: Poland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 66: Romania Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 67: Russia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 68: Russia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 69: North America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 70: North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 71: North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 72: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, North America Countries
  • Table 73: North America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 74: Canada Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 75: Mexico Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 76: USA Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 77: USA Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 78: South America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 79: South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 80: South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 81: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, South America Countries
  • Table 82: South America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 83: Argentina Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 84: Brazil Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 85: Brazil Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 86: Chile Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 87: Colombia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 88: Peru Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 89: Venezuela Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 90: Middle East, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 91: Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 92: Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 93: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Middle East Countries
  • Table 94: Middle East Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 95: Saudi Arabia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 96: Israel Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 97: Turkey Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 98: UAE Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 99: Africa, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 100: Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 101: Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 102: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Africa Countries
  • Table 103: Africa Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 104: Egypt Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 105: Nigeria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 106: South Africa Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 107: Takeda Pharmaceticals Financial Performance
  • Table 108: Bayer AG Financial Performance
  • Table 109: Abbott Laboratories Financial Performance
  • Table 110: Otsuka Holdings Co ltd Financial Performance
  • Table 111: Johnson & Johnson Financial Performance
  • Table 112: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Table 113: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 114: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 115: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Table 116: Global Gastrointestinal Drugs Market In 2026- Growth Countries
  • Table 117: Global Gastrointestinal Drugs Market In 2026- Growth Segments
  • Table 118: Global Gastrointestinal Drugs Market In 2026- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Gastrointestinal Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 4: Global Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 5: Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Gastrointestinal Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Gastrointestinal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Global Gastrointestinal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Global Gastrointestinal Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: Global Gastrointestinal Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Gastrointestinal Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Figure 12: Per Capita Average Gastrointestinal Drugs Market Expenditure, 2016-2026, Global
  • Figure 13: Asia-Pacific, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 14: Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 15: Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 16: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Figure 17: Asia-Pacific Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 18: China Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 19: China Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 20: Australia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 21: Australia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 22: Hong Kong Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 23: India Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 24: India Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 25: Indonesia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 26: Indonesia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 27: Japan Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 28: Japan Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 29: Malaysia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 30: New Zealand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 31: Philippines Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 32: Singapore Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 33: South Korea Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 34: Thailand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 35: Vietnam Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 36: Western Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 37: Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 38: Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 39: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Western Europe Countries
  • Figure 40: Western Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 41: Austria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 42: Belgium Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 43: Denmark Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 44: Finland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 45: France Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 46: France Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 47: Germany Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 48: Germany Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 49: Ireland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 50: Italy Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 51: Netherlands Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 52: Norway Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 53: Portugal Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 54: Spain Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 55: Sweden Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 56: Switzerland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 57: UK Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 58: UK Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 59: Eastern Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 60: Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 61: Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 62: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Figure 63: Eastern Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 64: Czech Republic Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 65: Poland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 66: Romania Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 67: Russia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 68: Russia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 69: North America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 70: North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 71: North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 72: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, North America Countries
  • Figure 73: North America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 74: Canada Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 75: Mexico Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 76: USA Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 77: USA Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 78: South America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 79: South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 80: South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 81: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, South America Countries
  • Figure 82: South America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 83: Argentina Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 84: Brazil Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 85: Brazil Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 86: Chile Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 87: Colombia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 88: Peru Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 89: Venezuela Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 90: Middle East, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 91: Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 92: Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 93: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Middle East Countries
  • Figure 94: Middle East Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 95: Saudi Arabia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 96: Israel Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 97: Turkey Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 98: UAE Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 99: Africa, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 100: Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 101: Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 102: Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Africa Countries
  • Figure 103: Africa Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 104: Egypt Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 105: Nigeria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 106: South Africa Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 107: Takeda Pharmaceticals Financial Performance
  • Figure 108: Bayer AG Financial Performance
  • Figure 109: Abbott Laboratories Financial Performance
  • Figure 110: Otsuka Holdings Co ltd Financial Performance
  • Figure 111: Johnson & Johnson Financial Performance
  • Figure 112: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Figure 113: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 114: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 115: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Figure 116: Global Gastrointestinal Drugs Market In 2026- Growth Countries
  • Figure 117: Global Gastrointestinal Drugs Market In 2026- Growth Segments
  • Figure 118: Global Gastrointestinal Drugs Market In 2026- Growth Strategies
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Antacids Global Market Report 2024 – By Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents), By Formulation Type (Tablet, Liquid, Powder, Other Formulation Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Gastrointestinal Bleeding Treatment Devices Global Market Report 2024 – By Product (Endoscopic Thermal Devices, Other Products), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End User (Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Gastrointestinal Devices Global Market Report 2024 – By Product Type (GI Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopy, Endoscopic Ultrasound, Endoscopic Mucosal Resection (EMR), Hemostasis Devices, Other Product Types), By Sales Channel (Online Retailing, Medical Stores & Brand Outlet), By End Users (Hospitals, Clinics & Dialysis Centers, Ambulatory Surgical Center) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Biosimilar Therapeutic Peptides Global Market Report 2024 – By Type (Innovative, Generic), By Route Of Administration (Parenteral Route, Transdermal Route, Other Route Of Administrations), By Application (Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Clinical Nutrition Global Market Report 2024 – By Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), By Route Of Administration (Oral, Enteral, Parenteral), By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, Other Applications), By End User (Pediatric, Adults, Geriatric) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Endoscopy Devices And Equipment Global Market Report 2024 – By Product (Endoscope, Endoscopy Operative Devices, Endoscopy Visualization Systems), By Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuroendoscopy, Gastrointestinal Endoscopy, Obstetrics/Gynecology Endoscopy, ENT Endoscopy, Other Applications), By End-User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Human Microbiome Therapeutics Market - By Disease (Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers), By Sequencing Technology Type (Targeted Gene, RNA, Whole-Genome Shotgun (WGS)) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Antidiarrhoeals Global Market Report 2023 – By Drug Class (Mucosal Protectants, Motility Modifying Drugs), By Application (Adults, Childrens), By Type (OTC drugs, Prescription Drugs) – Market Size, Trends, And Global Forecast 2023-2032
View Report

Frequently Asked Questions

What is the definition of the gastrointestinal drugs market?

The gastrointestinal drugs market consists of sales of gastrointestinal drugs by entities that produce gastrointestinal drugs to treat gastrointestinal diseases such as ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome request a sample here

How will the gastrointestinal drugs market drivers and restraints affect gastrointestinal drugs market dynamics? What forces will shape the gastrointestinal drugs industry going forward?

The gastrointestinal drugs market growth is aided by the aging population profile of most countries. However, some gastrointestinal drugs market restraints include patent expiration of branded gastrointestinal drugs. request a sample here

What is the forecast market size of the gastrointestinal drugs market?

The gastrointestinal drugs market forecast is expected to reach $62.19 billion in 2025 at a compound annual growth rate of 6%. request a sample here

How is the gastrointestinal drugs market segmented?

The global gastrointestinal drugs market is segmented -
1) By Type: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs request a sample here

Which region has largest share, and what is the market size and growth by geography according to the gastrointestinal drugs global market report?

For more detail on this, request a sample here.

Who are the key players of the global gastrointestinal drugs market?

Top competitors in the gastrointestinal drugs market are Takeda Pharmaceticals, Allergan Plc, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson. request a sample here.

What are the key trends in the global gastrointestinal drugs market?

Major trends influencing the gastrointestinal drugs market include investment in making oral capsules of macromolecular drugs for gastrointestinal diseases for making the drug more effective request a sample here.

What are the major opportunities in the gastrointestinal drugs market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global gastrointestinal drugs market, request a sample here.

How does the gastrointestinal drugs market relate to the overall economy and other similar markets?

request a sample here.

request a sample here.

request a sample here.